Hydra Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Hydra Biosciences's estimated annual revenue is currently $1.6M per year.
- Hydra Biosciences's estimated revenue per employee is $155,000
Employee Data
- Hydra Biosciences has 10 Employees.
- Hydra Biosciences grew their employee count by -17% last year.
Hydra Biosciences's People
| Name | Title | Email/Phone |
|---|
Hydra Biosciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Hydra Biosciences?
Hydra Biosciences is a privately held clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, that develops drugs to treat pain, inflammation, renal disease, anxiety and pulmonary disease using its expertise in novel ion channels. Hydra Biosciences' proprietary platforms enable the company to identify and develop drug candidates that address significant unmet medical needs.
keywords:N/A
N/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Hydra Biosciences News
... Boehringer Ingelheim GmbH, Daiichi Sankyo Company, Limited, Dong-A Socio Group, Eli Lilly and Company, Glenmark Pharmaceuticals Ltd., Hydra Biosciences.
... Axikin Pharmaceuticals, Chiesi Farmaceutici SpA, CSL Limited, Circassia Pharmaceuticals Plc, Fountain Biopharma Inc., Hydra Biosciences,...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 10 | N/A | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $0.9M | 10 | N/A | N/A |
#4 | $0.9M | 10 | N/A | N/A |
#5 | $0.8M | 10 | N/A | N/A |